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Cleveland, OhioObjectives This study sought to investigate the frequency, predictors, and detailed qualitative and
quantitative assessment of optical coherence tomography (OCT)-detected stent edge dissections. Its
impact on subsequent management and clinical outcomes were also investigated.
Background OCT is a high-resolution imaging modality that can lead to more frequent recognition
and accurate assessment of vascular injuries during percutaneous coronary intervention (PCI).
Methods From September 2010 to June 2011, all patients with OCT post-PCI were enrolled. Edge
dissections were deﬁned as disruptions of the arterial lumen surface in both the 5-mm distal and
proximal stent edges. Qualitative and quantitative analyses of all edges were performed at 0.2-mm
intervals.
Results In total, 395 edges (249 lesions in 230 patients) were analyzed. The overall incidence of
OCT-detected edge dissection was 37.8%, and most (84%) were not apparent on angiography.
Independent predictors for OCT-detected dissections were presence of atherosclerotic plaque at stent
edges, calciﬁcation angle, minimum ﬁbrous cap thickness, thin-cap ﬁbroatheromas, stent/lumen
eccentricity, and vessel overstretching. Mean dissection length measured 2.04  1.60 mm, 96.2%
appeared as ﬂaps, and 52.8% extended beyond the intima/atheroma layer. Additional stenting was
performed in 22.6% of all dissections, which were longer, had bigger dimensions, and promoted
deeper vascular injury. The 12-month major adverse cardiac event rate was similar between patients
with (7.95%) and without (5.69%, p ¼ 0.581) dissections.
Conclusions High rates of stent edge dissections were detected by OCT, usually related to the
presence of atherosclerosis at stent edges and to PCI technique. Detailed OCT assessment of
dissection severity was possible and affected the subsequent management of this complication.
Non–ﬂow-limiting, small, and superﬁcial dissections left untreated proved benign. (J Am Coll Cardiol
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Abbreviations
and Acronyms
FC = ﬁbrous cap
IVUS = intravascular
ultrasound
MACE = major adverse
cardiac event(s)
MI = myocardial infarction
OCT = optical coherence
tomography
OR = odds ratio
PCI = percutaneous coronary
intervention
TCFA = thin-cap
ﬁbroatheroma
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801Plaque fracture and dissection of the arterial wall are key
mechanisms of lumen enlargement after balloon angioplasty
(1,2). During stent implantation, unplanned vessel tearing
may occur at the transition between the rigid stent struts and
the adjacent arterial wall (3), which has been associated with
increased risks of thrombosis and major adverse cardiac
events (MACE) (4–8).
Coronary angiography (9) and intravascular ultrasound
(IVUS) (3,10) have traditionally been used for the diagnosis
of dissections at stent edges. Reported incidences of stent
edge dissection range from 5% to 23% of the percutaneous
coronary intervention (PCI) procedures as detected by IVUS
(3). The superior resolution (12 to 18 mm) (11) of light-
based optical coherence tomography (OCT) compared with
IVUS (150 to 250 mm) may lead to more frequent recog-
nition of vascular injury during PCI (12,13). Although
physicians welcome better imaging and more knowledge of
the vascular response to PCI, they face a clinical dilemma on
the subsequent management of OCT ﬁndings. Recent
reports provided early insights on the incidence and char-
acteristics of stent edge dissections by OCT (14,15), but the
inherent selection bias of retrospective, small studies have
limited our understanding of the true incidence and clinical
implications of OCT-detected stent edge dissections.
Therefore, the goals of the present study were to: 1) deter-
mine the frequency of stent edge dissections by OCT in
a large, unrestricted population representative of the daily
clinical practice; 2) perform a detailed morphometric
assessment of stent edge dissections and identify potential
factors associated with its occurrence; 3) assess the impact of
the OCT ﬁndings on the clinical management of edge
dissections in real practice; and 4) examine the clinical
outcomes of OCT-detected edge dissections.
Methods
Study population, study design, and PCI procedures. OCT
was adopted as the standard intravascular imagingmodality at
our Institution after its approval by the U.S. Food and Drug
Administration in May 2010. The University Hospitals Case
Medical Center OCT Program is a prospective initiative
approved by the local institutional review board, and
comprises 2 distinct phases: Phase I (September to October
2010) was a quality initiative program designed to evaluate
safety, feasibility, and clinical impact of OCT usage on
patient management in the daily practice. During this phase,
OCT was performed in all patients undergoing a coronary
intervention or requiring an invasive evaluation of interme-
diate coronary lesions (16). There were no pre-deﬁned
exclusion criteria, thus representing an “all-comers,” unre-
stricted use of OCT; Phase II, fromNovember 2010 onward,
comprised the “real-world” clinical utilization of OCT per the
operator’s discretion, thus representing a “selective use” of
OCT in routine practice. All patients submitted to OCTexamination from September 2010 to June 2011 were
prospectively entered into a dedicated database, and comprise
the population included in the current analysis.
PCI was performed per standard practice. Patients were
treated with a loading dose of aspirin 300 mg and clopi-
dogrel 300 mg or 600 mg. At the beginning of the proce-
dure, a weight-adjusted (100 IU/kg) bolus of unfractionated
heparin or a bolus of bivalirudin (0.75 mg/kg) was admin-
istered. Additional heparin boluses or continuous intrave-
nous infusion of bivalirudin 1.75 mg/kg/h were given in
order to maintain an activated clotting time 250 s.
Glycoprotein IIb/IIIa inhibitors were used as per the oper-
ator’s discretion. OCT imaging was mandatory in Phase I
and left at the operator’s discretion during Phase II. No
formal recommendations were given regarding the
management of stent edge dissection identiﬁed by OCT,
which allowed proper assessment of the operator reaction to
OCT ﬁndings without bias.
Angiographic analysis. All angio-
grams were analyzed off-line for
the presence of stent edge dissec-
tions by 2 experienced inter-
ventional cardiologists blinded to
the OCT ﬁndings. The target
lesion was classiﬁed according to
the American College of Cardi-
ology/American Heart Associa-
tion classiﬁcation system (17).
Severe calciﬁcation was charac-
terized by the presence of radio-
pacities noted without cardiac
motion before contrast injection,
and generally compromising both
sides of the arterial lumen (18).
Severe angulation was deﬁned as
an artery bend >60 (17). Haziness was characterized as
the presence of nonhomogeneous reduced contrast density
within the arterial lumen, not fulﬁlling the criteria of
deﬁnite thrombus or dissection (19,20). The step-up/
step-down phenomenon was characterized by an abrupt
transition of the vessel caliber between the proximal and
distal stent borders to its respective references (21). Severity
of stent edge dissections was classiﬁed according to the
National Heart, Lung, and Blood Institute criteria as types
A through F (9). Final coronary epicardial ﬂow was clas-
siﬁed according to the Thrombolysis In Myocardial
Infarction criteria from 0 to 3 (22).
OCT image acquisition and analysis. OCT images were
acquired with a commercially available Fourier-Domain
OCT system (C7 XR OCT Intravascular Imaging System,
St. Jude Medical, St. Paul, Minnesota) after intracoronary
administration of 100 to 200 mg of nitroglycerin (unless
clinically contraindicated) through conventional 6-F or 7-F
guiding catheters. A 0.014-inch angioplasty guidewire was
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802positioned distally in the target vessel, and the OCT catheter
(C7 Dragonﬂy, St. Jude Medical) was advanced at least 10
mm distal to the distal stent edge. The entire length of the
stented region was scanned using an integrated automated
motorized pullback device at a speed of 20 mm/s. Contin-
uous ﬂush of iodine contrast medium (8 to 20 ml), through
a power injector (3 to 7 ml/s at 300 psi), was performed to
create a virtually blood-free environment and to trigger
image acquisition. In cases with stented segments longerFigure 1. OCT Qualitative and Morphometric Assessment of Stent Edges
(A) Left: dissection ﬂap; center: lumen segmentation outlining the ﬂap (solid blue tra
surface to the joint point with the vessel wall at the base of the ﬂap; b. openingddista
the gravitational center of the lumen; c. lengthdmeasured from the tip of the ﬂap
planimetry of the region outlined by the lumen contours incorporating (solid blue
cavity; center: lumen segmentation outlining the cavity region (solid blue tracing) an
(solid green tracing); right: cavity morphometric parameters: a. depth–line projected
cavity to the second lumen contour; b. openingddistance between the points wher
lumen area bounded by the 2 lumen contours. (C) Dissection axial depthdleft: inti
hematoma; center: lumen (blue contour) and hematoma area segmentation (red sh
white thrombus (solid white arrow). OCT ¼ optical coherence tomography.than 54 mm (the maximum scan length of the current OCT
system), performance of another pullback was recommended
to ensure visualization of the proximal stent edge. All OCT
images were digitally stored and submitted to the institu-
tion’s cardiovascular imaging core laboratory for off-line
independent analysis.
All OCT runs were carefully screened for quality, and
stent edges with <5 mm length or those with poor visual-
ization due to artifacts or inadequate blood clearance werecing); right: ﬂap morphometric parameters: a. depthddistance from the luminal
nce from the tip of the ﬂap to the lumen contour along a line projected through
to the joint point of the ﬂap with the vessel wall; and d. area (white region)d
tracing) and interpolating (black dotted tracing) the ﬂap. (B) Left: dissection
d another contour overlapping the ﬁrst and interpolating each side of the cavity
through the gravitational center of the lumen from the deepest point inside the
e the 2 lumen contours intersect; and c. area (white region)dplanimetry of the
mal; center: medial; right: adventitial. (D) Left: ﬂap dissection with intramural
aded region); and right: dissection ﬂap (dotted white arrow) with intraluminal
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803excluded. All images were analyzed at 0.2-mm (every-frame)
intervals with dedicated automated contour-detection soft-
ware (OCT system software B.0.1, St. Jude Medical).
Stent borders were deﬁned as the ﬁrst and last cross
sections of the stented segment where struts could be seen in
all 4 quadrants of the image. The peristent region consisted
of the ﬁrst frame immediately following the stent border (0.2
mm apart). Stent edges were deﬁned as the 5-mm regions
immediately adjacent to the stent borders, both distally and
proximally. Edge dissection was deﬁned as disruptions of the
arterial lumen surface in the stent edge segment seen in at
least 2 consecutive cross-section images. Its longitudinal
length was calculated by multiplying the number ofFigure 2. Relationship of Atherosclerotic Disease at Stent Edges and Dissection
(A) Stent landing zone assessmentdstent borders were positioned over a “normal”
ferential (right) plaque distribution. (B) Left: ﬁbrotic plaque–related dissection; cent
dissection. (C) Left: calciﬁcation (solid yellow contour) quantiﬁcation. Circumferentia
on the lumen (red solid arrows). Calcium-to-lumen distance (white solid lines) wa
lumen contour at a 15 interval (red dotted lines), and the average value was taken;
of the FC coincides with the lumen contour, and the abluminal boundary was automa
pixel intensity transition between the FC and lipid/necrotic core. The minimal distanc
was automatically computed, and the minimum and mean FC thicknesses were record
arc length of the FC summed over involved frames (26). The red and green arrowsconsecutive cross sections containing dissection by the slice
thickness (pullback speed [mm/s]  frame rate [s]).
Dissections were morphologically classiﬁed as ﬂaps and
cavities. Speciﬁc morphometric parameters for each ﬂap
(Fig. 1A) and cavity (Fig. 1B) were calculated to estimate
the magnitude of dissections.
The severity of each dissection was further estimated
according to a qualitative assessment of the depth of vessel
injury as: 1) intimal (limited to the intima layer or atheroma);
2) medial (extending into the media layer); and 3) adventitial
(extending through the external elastic membrane) (23)
(Fig. 1C). Presence of intramural hematoma was deﬁned as
an accumulation of ﬂushing medium (or blood) within thes
vessel segment (left) or a diseased region with eccentric (center) or circum-
er: ﬁbrocalciﬁed plaque–related dissection; right: lipid-rich plaque–related
l calcium distribution (degrees of arc) was measured using a protractor centered
s determined as the distance between the luminal edge of the calcium and the
right: ﬁbrous cap (FC) quantiﬁcation in lipid-rich plaques. The luminal boundary
tically identiﬁed by a dynamic program algorithm that discriminates the optimal
e from every locus in the luminal boundary of the FC to its abluminal boundary
ed. FC surface area was determined as the product of the frame interval, and the
indicate the minimum and maximum FC thicknesses, respectively.
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804medial space, displacing the internal elastic membrane
inward and the external elastic membrane outward (23). The
intramural hematoma area was determined by planimetry,
and its longitudinal length calculated (Fig. 1D). Intraluminal
thrombus was characterized as a mass attached to the luminal
surface or ﬂoating within the lumen (23) (Fig. 1D).
Presence of atherosclerotic disease at the stent edges was
investigated (Fig. 2). A “normal” vessel was characterized by
the presence of a 3-layered architecture comprising the
evidence of intimal, medial, and adventitial layers (23) with
an intimal thickness <250 mm (24). Whenever atheroscle-
rotic disease was present, plaques were classiﬁed according to
previously described criteria as ﬁbrotic, ﬁbrocalciﬁc, or lipid-
rich (23,25) (Fig. 2B). Circumferential distribution of
calcium and calcium-to-lumen distance were determined forFigure 3. Study Flowchart
Flowchart showing inclusion and exclusion of subjects in each study phase. Incidenc
study phase. NIH ¼ neointimal hyperplasia; OCT ¼ optical coherence tomography; P
Medical Center.all calciﬁed plaques (Fig. 2C). In lipid-rich plaques, the
entire extension of the overlying ﬁbrous cap (FC) was
semiautomatically segmented using a custom-built software,
and the FC surface area and its minimum and mean
thicknesses were automatically calculated (26) (Fig. 2C).
Thin-cap ﬁbroatheroma (TCFA) was deﬁned as a lipid-rich
plaque with minimum FC thickness 65 mm (27).
At the stent border, the stent area was measured, and the
stent eccentricity index was calculated as: (maximum stent
diameter  minimum stent diameter)/maximum stent
diameter. Lumen eccentricity index was determined as
(maximum lumen diameter  minimum lumen diameter)/
maximum lumen diameter. Lumen area stenosis was calcu-
lated as: ([mean lumen area  minimum lumen area]/mean
lumen area  100). Stent diameter/lumen diameter ratioe of OCT-detected dissection is presented for the total population and for each
CI ¼ percutaneous coronary intervention; UH-CMC ¼ University Hospitals Case
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805and stent area/lumen area ratio were calculated at the peri-
stent region and the 5-mm edges to investigate the degree of
vessel stretching by the stent.
Patient follow-up and clinical outcomes. Patients were fol-
lowed up by telephone or hospital visit at 1, 6, and 12
months. MACE was recorded in a cumulative and hierar-
chical fashion, comprising the composite of death, nonfatal
myocardial infarction (MI), and target lesion revasculariza-
tion. Unless otherwise documented, all deaths were
considered of cardiac origin. Occurrence of MI was deﬁned
according to the Joint ESC/ACCF/AHA/WHF Task
Force for Redeﬁnition of Myocardial Infarction (28).
Target lesion revascularization was deﬁned as any revas-
cularization procedure (either PCI or coronary artery bypass
graft) of the target lesion in the presence of angiog-
raphic restenosis and signs and symptoms of ischemia.
Target vessel revascularization was deﬁned as any repeat
revascularization (either PCI or coronary artery bypass graft)
of the target vessel, including upstream and downstream
branches and the target lesion itself. Stent thromboses were
classiﬁed according to the Academic Research Consortium
criteria (29).
Statistical analysis. All statistical analyses were performed
using SAS software version 9.2 (SAS Institute, Cary, North
Carolina), and statistical signiﬁcance was assessed at the 0.05
level. Continuous variables are expressed as mean  SD, and
categorical variables are expressed as counts and percentages.
For per-patient analyses, differences between the 2 groups
were evaluated by the unpaired Student t test for continuous
variables, and Fisher exact test for categorical variables. ToTable 1. Baseline Clinical Characteristics
Overall
(n ¼ 230)
D
(
Age, yrs 63.04  12.27 66.9
Male 148 (64.3) 5
Diabetes mellitus 71 (30.9) 3
Hypertension 187 (81.3) 7
Dyslipidemia 182 (79.1) 7
Smoking (current) 74 (32.2) 1
Prior MI 71 (30.9) 3
Prior PCI 63 (27.4) 2
Prior CABG 18 (7.8)
PCI indication
Silent ischemia 17 (7.4) 1
Stable angina 55 (23.9) 2
ACS
Unstable angina 63 (27.4) 2
NSTEMI 53 (23.0) 2
STEMI 42 (18.3)
Values are mean  SD or n (%). p Value is for comparison between
ACS ¼ acute coronary syndrome; CABG ¼ coronary artery bypass
elevation myocardial infarction; PCI ¼ percutaneous coronary intervestimate the differences between the 2 groups at the lesion or
segment level, multilevel mixed models (which can address
random effects at lesion, vessel, and subject levels) were used
for binary and continuous outcomes comparison. Multivar-
iate logistic regression models considering hierarchical data
structure were developed, and odds ratios (ORs) were used to
evaluate factors associated with dissection identiﬁcation after
adjusting signiﬁcant univariate predictors.
Results
Incidence of OCT-detected stent edge dissection. Overall,
321 patients (345 lesions in 339 vessels) underwent intra-
coronary OCT investigation between September 2010 and
June 2011, and during this period, OCT was performed
after stenting in 266 patients (290 lesions in 276 vessels).
After excluding cases in which OCT analysis could not be
performed in part or in all of the pre-deﬁned 5-mm edge
segments, there were available for the ﬁnal analysis a total of
395 stent edges (from 249 lesions in 236 vessels of 230
patients). A ﬂowchart with the reasons for exclusion and the
number of cases included in each phase of the study is
presented in Figure 3. Overall, the incidence of OCT-
detected stent edge dissection was 39.1% per patient (90 of
230 patients), 38.6% per vessel (91 of 236 vessels), 37.8%
per lesion (94 of 249 lesions), and 26.8% per stent edge (106
of 395 edges). Although not signiﬁcant, OCT-detected
edge dissections were slightly more frequent during the
study’s Phase II (42.6% [52 of 122] of the patients; 41.7%
[53 of 127] of the vessels; 40.9% [56 of 137] of the lesions;issection
n ¼ 90)
No Dissection
(n ¼ 140) p Value
7  11.13 60.50  12.34 <0.001
4 (60.0) 94 (67.1) 0.270
3 (36.7) 38 (27.1) 0.127
9 (87.8) 108 (77.1) 0.044
6 (84.4) 106 (75.7) 0.112
8 (20.0) 56 (40.0) 0.002
2 (35.6) 39 (27.9) 0.217
6 (28.9) 37 (26.4) 0.683
7 (7.8) 11 (7.9) 0.983
0.043
0 (11.1) 7 (5.0)
0 (22.2) 35 (25)
9 (32.2) 34 (24.3)
2 (24.4) 31 (22.1)
9 (10.0) 33 (23.6)
patients with and without stent edge dissection.
graft; MI ¼ myocardial infarction; NSTEMI ¼ non–ST-segment
ention; STEMI ¼ ST-segment elevation myocardial infarction.
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806and 28% [60 of 214] of the analyzed edges) than in Phase I
(35.2% [38 of 108] of the patients; 34.9% [38 of 109] of the
vessels; 33.9% [38 of 112] of the lesions; and 25.4% [46 of
181] of the edges; p ¼ 0.280 for patient-level, p ¼ 0.369 for
vessel-level, p ¼ 0.371 for lesion-level, and p ¼ 0.542 for
edge-level comparisons). Dissections were more frequently
located at distal edges (67.9%; 72 of 106 edges) than at
proximal edges (32.1%; 34 of 106 edges). Nine of 90
patients (10%) presented dissections at both distal and
proximal edges of the same lesion, and 4 patients (4.4%)
presented at least 1 dissection in more than 1 treated lesion
in the same vessel.Table 2. Baseline Angiographic Data
Overall
(n ¼ 249 Lesions)
Target vessel
LAD 114 (45.6)
LCX 59 (23.6)
RCA 67 (26.8)
LM 3 (1.2)
SVG 6 (2.4)
Angulation >60 22 (8.8)
Calcium (severe) 62 (24.9)
Bifurcation 46 (18.5)
Total occlusion (>3 months) 2 (0.8)
In-stent restenosis 17 (6.8)
ACC/AHA lesion class
A/B1 76 (30.5)
B2/C 173 (69.5)
Pre-PCI TIMI ﬂow grade
0–2 45 (18.1)
3 204 (81.9)
Lesion length, mm 19.75  12.52
Reference vessel diameter, mm 2.81  0.74
Minimum lumen diameter, mm 0.80  0.52
Diameter stenosis, % 70.85  17.10
Stents per lesion 1.21  0.47
Stent type
Xience V/Promus 185 (74.3)
Cypher 95 (38.2)
Endeavor 3 (1.2)
BMS 19 (7.6)
Nominal stent diameter, mm 2.99  0.46
Total stented length, mm 26.63  12.66
Maximum balloon diameter, mm 3.30  0.57
Maximum inﬂation pressure, atm 18.02  3.66
Post-PCI TIMI ﬂow
0–2 2 (0.8)
3 247 (99.2)
Values are n (%) or mean  SD. p value is for comparison between lesions
ACC/AHA ¼ American College of Cardiology/American Heart Association
LCX ¼ left circumﬂex artery; LM ¼ left main coronary artery; PCI ¼
SVG ¼ saphenous vein graft; TIMI ¼ Thrombolysis In Myocardial Infarction.Baseline clinical, angiographic, and procedural characteristics.
Baseline clinical characteristics are presented in Table 1. The
population with stent edge dissection was older, had higher
rates of hypertension, and had a lower incidence of smokers
in comparison to the group without dissection. Acute coro-
nary syndromes were responsible for 68.7% of all PCI
indications. Baseline angiographic characteristics are pre-
sented in Table 2. The left anterior descending artery was the
most frequently treated vessel in both groups. In comparison
to the group without dissection, patients with edge dissection
had more complex (American College of Cardiology/
American Heart Association type B2/C) lesions (79.8% vs.Dissection
(n ¼ 94 Lesions)
No Dissection
(n ¼ 155 Lesions) p Value
0.168
41 (43.6) 73 (47.1)
24 (25.5) 35 (22.6)
25 (26.6) 42 (27.1)
3 (3.2) 0 (0.0)
1 (1.1) 5 (3.2)
14 (14.9) 8 (5.2) 0.041
40 (42.5) 22 (14.2) 0.002
9 (9.6) 37 (23.8) 0.031
1 (1.1) 1 (0.6) 0.732
7 (7.4) 10 (6.5) 0.806
0.034
19 (20.2) 57 (36.8)
75 (79.8) 98 (63.2)
0.521
15 (16.0) 30 (19.3)
79 (84.0) 125 (80.7)
22.01  13.05 18.38  12.02 0.091
2.61  0.67 2.93  0.76 0.011
0.69  0.47 0.88  0.55 0.027
71.81  19.56 69.81  16.39 0.419
1.30  0.50 1.16  0.41 0.020
0.084
79 (84.0) 106 (68.4)
32 (34.0) 63 (40.6)
3 (3.2) 0 (0.0)
8 (8.5) 11 (7.1)
2.91  0.39 3.03  0.48 0.019
29.06  13.99 25.19  11.60 0.028
3.16  0.48 3.38  0.59 0.002
18.24  3.88 17.89  3.52 0.484
0.734
1 (1.1) 1 (0.6)
93 (98.9) 154 (99.4)
with and without stent edge dissection.
; BMS ¼ bare metal stent(s); LAD ¼ left anterior descending artery;
percutaneous coronary intervention; RCA ¼ right coronary artery;
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80763.2%, p ¼ 0.034), higher prevalence of severe vessel
angulation (14.9% vs. 5.2%, p ¼ 0.041), and severe calciﬁ-
cation (42.6% vs. 14.3%, p ¼ 0.002), smaller reference vessel
diameters (2.61  0.67 vs. 2.93  0.76, p ¼ 0.011), and
smaller minimal lumen diameters (0.69  0.47 vs. 0.88 
0.55, p ¼ 0.027).
Only 17 (16%) of the total 106 edge dissections identiﬁed
by OCT were also visualized by angiography, of which 14
(82.4%) were deemed type A, and 3 (17.6%) type B. Lesions
with OCT-detected edge dissection had a higher prevalence
of haziness (2.1% vs. 5.7%, p ¼ 0.084) and step-up/step-
down (8.8% vs. 19.8%, p ¼ 0.001) by angiography. There
were no cases of false-positive dissections indicated by
angiography. No signiﬁcant angiographic differences were
observed between distal and proximal dissected edges
(Fig. 4).
OCT qualitative assessment of stent edges. Qualitative
assessment of stent edges by OCT is presented in Table 3.
Overall, a high frequency of atherosclerotic plaques was seen
at stent edges, particularly at OCT-detected dissected edges
(95.3% vs. 75.4%, p < 0.001). Fibrotic plaques were moreFigure 4. Angiographic Appearance of Stent Edges
(A) Angiographic appearance of edges with and without dissection. (B) Angiograph
coherence tomography (OCT).frequent in nondissected edges (50.0% vs. 35.6%,
p ¼ 0.029). Edges with dissection had wider (125.76 
77.94 vs. 65.39  44.30, p < 0.001) and more superﬁcial
calciﬁcations (calcium-to-lumen distance: 0.07  0.07 mm
vs. 0.15  0.12 mm, p ¼ 0.002) than nondissected edges.
Likewise, lipid plaques in dissected edges showed a trend
towards a larger circumferential distribution, and had smaller
minimum FC thickness (65.90  38.33 mm vs. 103.07 
44.63 mm, p ¼ 0.018). TCFAs were signiﬁcantly more
frequent at dissected edges than at nondissected edges
(58.3% vs. 19%, p ¼ 0.037).
Atherosclerotic disease was similarly encountered at both
distal and proximal dissected edges. Although ﬁbrotic pla-
ques were more prevalent at distal edges (47.1% vs. 12.1%,
p ¼ 0.022), lipid plaques had signiﬁcantly thinner FCs at
proximal edges (60.83  30.90 mm vs. 70.97  45.41 mm,
p ¼ 0.044) (Online Table 1).
OCT quantitative assessment of stent edges. Quantitative
OCT assessment is also presented in Table 3. Despite higher
stent eccentricity in edges with dissection (0.11  0.08 vs.
0.08  0.05, p < 0.001), similar stent areas were observed inic appearance of distal and proximal dissected edges as detected by optical
Table 3. OCT Qualitative and Quantitative Analyses of Stent Edges
Dissection
(n ¼ 106)
No Dissection
(n ¼ 289) p Value
Plaque characteristics
Stent landing region
“Normal” vessel 5 (4.7) 71 (24.6) <0.001
Presence of atherosclerotic plaque 101 (95.3) 218 (75.4) <0.001
Circumferential distribution 36 (35.6) 79 (36.2) 0.238
Eccentric distribution 65 (64.4) 139 (63.8) 0.031
Plaque type
Fibrotic 36/101 (35.6) 109/218 (50.0) 0.029
Fibrocalciﬁc 41/101 (40.6) 67/218 (30.7) 0.137
Lipid-rich 24/101 (23.8) 42/218 (19.3) 0.351
Calcium quantiﬁcation
Angle, degrees 125.76  77.94 65.39  44.30 <0.001
Calcium-to-lumen distance, mm 0.07  0.07 0.15  0.12 0.002
Lipid-rich plaque quantiﬁcation
FC surface area, mm2 0.44  0.17 0.34  0.16 0.070
Average FC thickness, mm 149.33  43.40 167.40  54.11 0.209
Minimal FC thickness, mm 65.90  38.33 103.07  44.63 0.018
TCFA 14/24 (58.3) 8 (19.0) 0.037
Quantitative measurements
Stent border (inside the stent)
Stent area, mm2 6.51  2.76 7.43  2.97 0.208
Stent eccentricity index 0.11  0.08 0.08  0.05 <0.001
5-mm stent edge (outside the stent)
Lumen area, mm2 5.80  3.34 8.00  3.59 <0.001
MLA, mm2 4.76  3.15 7.08  3.34 <0.001
Lumen eccentricity index 0.22  0.07 0.14  0.08 <0.001
Post-PCI diameter stenosis, % 20.02  8.88 13.54  7.27 <0.001
Post-PCI area stenosis, % 20.28  11.70 11.96  8.22 <0.001
Vascular stretching
Peristent region
SD/LD 0.1.  0.07 0.96  0.06 <0.001
SA/LA 1.05  0.26 0.91  0.11 <0.001
5-mm stent edge
SD/mean LD 1.10  0.12 0.98  0.10 <0.001
SA/mean LA 1.20  0.26 0.96  0.19 <0.001
Values are n (%) or mean  SD.
FC ¼ ﬁbrous cap; LA ¼ lumen area; LD ¼ lumen diameter; MLA ¼ minimum lumen area;
OCT ¼ optical coherence tomography; PCI ¼ percutaneous coronary intervention; SA ¼ stent
area; SD ¼ stent diameter; TCFA ¼ thin-cap ﬁbroatheroma.
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808both dissected and nondissected edges. Mean lumen area and
minimal lumen area were signiﬁcantly smaller in dissected
edges, with higher lumen eccentricity in comparison to non-
dissected edges. After PCI, percent diameter stenosis and
percent area stenosis were also signiﬁcantly higher in dissected
edges.
Dissected edges had signiﬁcantly higher stent/artery
ratios. Interestingly, in comparison to distal dissected edges,
proximal dissected edges presented signiﬁcantly smaller
stent diameter/lumen diameter (1.04  0.13 vs. 1.13 0.11,
p ¼ 0.005) and stent area/lumen area (1.07  0.24 vs. 1.27
 0.25, p ¼ 0.006) ratios, suggesting that mechanismsbeyond vessel overstretching may contribute to dissections at
proximal stent edges (Online Table 1).
Predictors of OCT-detected stent edge dissection. Key
independent predictors for OCT-detected edge dissections
were the presence of atherosclerotic plaque at stent edges,
angle of calciﬁcation in ﬁbrocalciﬁc plaques, minimum FC
thickness in lipid-rich plaques, presence of TCFAs, stent
and lumen eccentricity, stent-to-lumen diameter, and area
ratios (Fig. 5).
Qualitative and morphometric analysis of stent edge dis-
sections. Overall, longitudinal dissection length measured
2.04  1.60 mm, and the majority of dissections appeared
as ﬂaps (96.2%). Forty-one dissected edges (38.7%) had
more than 1 ﬂap, and in 9 (8.5%) edges, ﬂap and cavity
coexisted. In most dissections, the depth of vascular injury
was beyond the intimal/atheroma layer (48.1% medial and
4.7% adventitial). Intramural hematoma was detected in
10 (9.4%) dissected edges, with 9 of them located at distal
edges. Only 1 intramural hematoma (10%) was located at
a nondiseased edge, and 9 (90%) were located at sites
with eccentric plaque. Intraluminal thrombus was detected
in 4 (3.8%) dissected edges, with equal distribution
between distal and proximal edges (Table 4). Dissections
concomitantly identiﬁed by OCT and angiography
(n ¼ 17) were longer, had bigger ﬂap dimensions, and had
deeper vessel injury than dissections seen only by OCT
(n ¼ 89). All dissections seen by both OCT and angi-
ography extended beyond the intimal/atheroma layer
(Online Table 2).
Management of stent edge dissections. Of all 106 dissec-
tions, 24 (22.6%) were treated with additional stents.
Treated dissections were longer and had more ﬂaps per
dissection, bigger ﬂap dimensions, and deeper degrees of
vascular injury in comparison to the dissections not treated
(Table 5). Incidence of intramural hematoma was similar
between the groups, and a trend was observed towards more
intraluminal thrombus in treated dissections. Of all
24 dissections treated, 13 (54.2%) had been identiﬁed by
both OCT and angiography, representing 76.5% of all
17 angiography-detected dissections. The rate of dissection
treatment was not signiﬁcantly different between the study’s
Phase I (9 of 46 [19.5%]) and Phase-II (15 of 60 [25%],
p ¼ 0.641), and no signiﬁcant differences were observed
regarding the morphometric parameters of dissections
between the 2 study phases (Table 5). Factors identiﬁed by
the multilevel univariate logistic regression analysis that
predicted the decision to treat an OCT-detected dissection
were the concomitant identiﬁcation of dissection by angi-
ography, dissection longitudinal length, and speciﬁc
morphometric parameters by OCT (Table 6).
Clinical outcomes. Clinical follow-up was available for 211
(91.74%) of the total 230 patients included in the study (88
of 90 patients [97.7%] with OCT-detected edge dissections
and 123 of 140 patients [87.8%] without dissections)
Figure 5. Multivariate Logistic Regression Analysis for Identiﬁcation of Independent Predictors of OCT-Detected Stent Edge Dissections
Forest plot and odds ratios show the association of several factors and the occurrence of stent edge dissection after adjusting signiﬁcant univariate clinical,
angiographic, and procedural predictors. CI ¼ conﬁdence interval; LA ¼ lumen area; LD ¼ lumen diameter; SA ¼ stent area; SD ¼ stent diameter; TCFA ¼ thin-cap
ﬁbroatheroma; other abbreviations as in Figure 1.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 6 , N O . 8 , 2 0 1 3 Chamié et al.
A U G U S T 2 0 1 3 : 8 0 0 – 1 3 OCT-Detected Stent Edge Dissections
809(Table 7). The mean follow-up time was 11.49  1.63
months for patients with dissection and 11.02  2.48
months for patients without dissection (p ¼ 0.120). There
were a total of 14 MACE (7 of 88 [7.95%] patients with
dissection vs. 7 of 123 [5.69%] patients without dissection
[p ¼ 0.581]). In the dissection group, there were 3 deaths
(1 of cardiac origin) and 4 nonfatal MIs, from which only
1 was related to the target lesion requiring revascularization.
Of note, all events occurred more than 30 days after the
index procedure, and happened in patients in whom the
dissections were only seen by OCT, as the majority of
dissections concomitantly seen by OCT and angiography
were treated. Edge dissections in patients with and without
MACE had similar morphometric characteristics (Online
Tables 3 and 4).
In the group of patients without dissection, there were
5 deaths (4 of cardiac origin) and 2 nonfatal MIs, from
which 1 was due to severe in-stent restenosis and required
revascularization. There were no stent thrombosis in the
edge dissection group and only 1 probable stent throm-
bosis in a patient without dissection who had a cardiac
death in the ﬁrst week after the index procedure
(Table 7).Discussion
We report the ﬁrst large comprehensive OCT evaluation of
arterial wall injury at stent edges in the daily clinical practice.
The present study led to the following observations: 1) edge
dissections after stenting are frequently detected by OCT,
with a “true” incidence of 33.9% when OCT was performed
in all treated vessels (Phase I) or a “real-world” rate of 40.9%
when OCT was selectively used per the operator’s discretion
(Phase II); 2) most OCT-detected edge dissections (84%)
were not apparent on angiography; 3) atherosclerotic disease
was frequent (95.3%) at dissected edges, with the odds of
having a dissection increasing by more than 6 times in the
presence of a plaque; 4) circumferential calcium angle, FC
thickness over lipid-rich plaques, and vessel overstretching
by the stent were independent predictors for the occurrence
of edge dissections; 5) a relatively high frequency (22.6%) of
OCT-detected dissections were treated with additional
stenting, which was driven by the concomitant presence of
dissection on angiography in addition to OCT ﬁndings; and
6) patients with untreated OCT-detected edge dissections
had similar 12-month outcomes compared with patients
without dissection.
Table 4. OCT Qualitative and Morphometric Analysis of Dissected Edges
Overall
(n ¼ 106)
Distal Edge
(n ¼ 72)
Proximal Edge
(n ¼ 34) p Value
Dissection longitudinal length, mm 2.04  1.60 2.03  1.60 2.06  1.65 0.951
Dissection appearance on OCT
Flap 102 (96.2) 69 (95.8) 33 (97.1) 0.768
Cavity 13 (12.3) 9 (12.5) 4 (11.8) 0.917
Number of ﬂaps per dissection 1.45  0.77 1.40  0.69 1.56  0.93 0.372
Number of cavities per dissection 0.12  0.33 0.13  0.33 0.12  0.33 0.895
Maximum ﬂap depth, mm 0.62  0.39 0.60  0.40 0.65  0.39 0.553
Maximum ﬂap opening, mm 0.39  0.34 0.37  0.36 0.42  0.28 0.489
Maximum ﬂap length, mm 1.09  0.67 1.05  0.70 1.19  0.61 0.324
Maximum ﬂap area, mm2 0.39  0.39 0.37  0.39 0.45  0.37 0.337
Maximum cavity depth, mm 0.46  0.25 0.43  0.29 0.52  0.16 0.581
Maximum cavity opening, mm 0.64  0.26 0.62  0.30 0.68  0.19 0.751
Maximum cavity area, mm2 0.20  0.16 0.17  0.18 0.26  0.11 0.380
Intramural hematoma 10 (9.4) 9 (12.5) 1 (2.9) 0.194
Hematoma longitudinal length 1.91  1.84 2.03  1.91 0.80 N/A
Maximum hematoma Area, mm2 0.92  0.60 0.88  0.63 1.19 N/A
Intraluminal thrombus 4 (3.8) 2 (2.8) 2 (5.9) 0.464
Depth of vessel injury
Intimal 50 (47.2) 34 (47.2) 16 (47.1) 0.984
Medial 51 (48.1) 34 (47.2) 17 (50.0) 0.803
Adventitial 5 (4.7) 4 (5.6) 1 (2.9) 0.574
Values are mean  SD or n (%). p value is for comparison between OCT-detected dissection at the distal and proximal edges.
OCT ¼ optical coherence tomography.
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810Incidence of stent edge dissection. Edge dissections post-
stenting have been observed in 5% to 23% of cases examined
by IVUS (3,30). A recent OCT investigation reported the
presence of stent edge dissections in 25% of 73 patients (14).
During the ﬁrst phase of the present study, edge dissections
were detected in 33.9% of 116 treated lesions examined by
OCT. Although these ﬁgures may represent the “true”
incidence of OCT-detected stent edge dissection, the
expected incidence of dissections in everyday practice may be
relatively higher (40.9%), likely because of more selective use
of OCT. Our ﬁndings further conﬁrm that dissections are
twice more likely to occur in distal edges in comparison to
proximal edges (67.9% vs. 32.1%) (7,14).
Predictors for stent edge dissection. Incomplete lesion
coverage has been associated with increased risk of proce-
dural complications and poor clinical outcomes (31,32). The
somewhat expected, yet alarming, high prevalence of
“untreated disease” found at stent margins is in part related
to PCI technique and limitations of angiography to properly
determine disease severity and extension. Only 4.7% of all
dissected edges were free of disease by OCT, contrasting to
24.6% of the nondissected edges (p < 0.001). The odds of
having an edge dissection were 6 times higher when the
stent was placed over a diseased region than over a normal
vessel (OR: 6.15, 95% conﬁdence interval: 2.09 to 18.11,
p ¼ 0.001). These results are in line with previous IVUSobservations (30,33) and underscores a modiﬁable factor,
that is, judicious PCI technique to minimize longitudinal
geographic miss, that may further improve PCI results.
Beyond the presence of disease at stent edges, the type of
plaque may also play an important role in the pathogenesis
of edge dissections. Previous work utilizing IVUS to
understand angiographic haziness at stent edges demon-
strated a signiﬁcantly higher prevalence of echolucent “soft”
plaques in patients with peristent injury than in controls
(20). In the current study, the majority of plaques were
ﬁbrotic or ﬁbrocalciﬁc in both dissected and nondissected
edges, and OCT-deﬁned lipid-rich plaques represented only
23.8% of plaques at dissected edges. Differences between
OCT and IVUS properties to detect lipid may explain these
somewhat discordant results on the association of lipid-rich
plaques and stent dissection. Our study, however, expands
upon these prior observations and shows that morphometric
aspects of FC overlying lipid/necrotic core pose signiﬁcant
risk for edge dissections. The incidence of TCFA was higher
in dissected edges than in nondissected edges, and minimum
FC thickness over lipid-rich plaques was signiﬁcantly
smaller. Furthermore, FC thickness was identiﬁed as an
independent predictor for the occurrence of edge dissections.
Based on an exploratory receiver-operating characteristic
curve analysis, a minimum FC thickness 80 mm was the
best cutoff to predict stent edge dissection on a lipid-rich
Table 5. OCT Qualitative and Morphometric Analysis of Dissected Edges According to Study Phase and
Management Strategy
Study Phase Management Strategy
Phase I
(n ¼ 46)
Phase II
(n ¼ 60) p Value
Treated
(n ¼ 24)
Not Treated
(n ¼ 82) p Value
Dissection longitudinal length, mm 2.04  1.45 2.04  1.73 0.991 3.03  1.41 1.75  1.55 0.007
Dissection appearance on OCT
Flap 45 (97.8) 57 (95.0) 0.538 24 (100) 78 (95.1) 0.737
Cavity 5 (10.9) 8 (13.3) 0.740 1 (4.2) 12 (14.6) 0.246
Number of ﬂaps per dissection 1.52  0.81 1.40  0.74 0.741 1.83  0.76 1.34  0.74 0.029
Number of cavities per dissection 0.11  0.31 0.13  0.34 0.545 0.04  0.20 0.15  0.36 0.219
Maximum ﬂap depth, mm 0.64  0.42 0.60  0.38 0.674 0.93  0.43 0.52  0.33 0.003
Maximum ﬂap opening, mm 0.36  0.25 0.41  0.39 0.570 0.58  0.29 0.33  0.33 0.014
Maximum ﬂap length, mm 1.12  0.64 1.07  0.70 0.972 1.64  0.58 0.93  0.61 0.003
Maximum ﬂap area, mm2 0.44  0.43 0.36  0.35 0.402 0.73  0.45 0.29  0.30 0.002
Maximum cavity depth, mm 0.42  0.21 0.49  0.29 0.682 0.75 0.44  0.25 N/A
Maximum cavity opening, mm 0.67  0.25 0.62  0.28 0.764 0.87 0.62  0.26 N/A
Maximum cavity area, mm2 0.20  0.14 0.20  0.18 0.990 0.41 0.18  0.15 N/A
Intramural hematoma 5 (10.9) 5 (8.3) 0.790 3 (12.5) 7 (8.5) 0.680
Hematoma longitudinal length 1.96  1.47 1.86  2.34 0.938 1.73  1.76 1.99  2.01 0.882
Maximum hematoma area, mm2 0.78  0.52 1.05  0.70 0.524 1.21  0.69 0.79  0.56 0.497
Intraluminal thrombus 2 (4.3) 2 (3.3) 0.812 3 (12.5) 1 (1.2) 0.083
Depth of vessel injury
Intimal 19 (41.3) 31 (51.7) 0.403 3 (12.5) 47 (57.3) 0.014
Medial 26 (56.5) 25 (41.7) 0.270 17 (70.8) 34 (41.5) 0.049
Adventitial 1 (2.2) 4 (6.7) 0.410 4 (16.7) 1 (1.2) 0.051
Values are mean  SD or n (%).
OCT ¼ optical coherence tomography.
Table 7. Cumulative 12-Month Clinical Outcomes
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811plaque, with a sensitivity and speciﬁcity of 73.9% and 72.5%,
respectively.
Presence of calciﬁcation has been traditionally identiﬁed
as an independent predictor of coronary dissection after
either balloon angioplasty or stent implantation (7,34,35).
Gonzalo et al. (14) assessed 24 stent edge dissections with
OCT and found ﬁbrocalciﬁc plaques (43.8%) to be more
frequent at distal dissected edges than were ﬁbrotic plaques
(10%, p ¼ 0.009). In the current study, we found a similar
frequency of ﬁbrocalciﬁc plaques in dissected edges (40.6%),Table 6. Factors Inﬂuencing Decision to Treat an OCT-Detected Edge
Dissection Based on Multilevel Univariate Logistic Regression Analysis
Odds Ratio
95% Conﬁdence
Interval p Value
Dissection identiﬁed by angiography 22.85 4.67–111.75 0.002
Maximum ﬂap area, mm2 21.73 3.10–152.51 0.008
Maximum ﬂap depth, mm 14.67 2.40–89.79 0.011
Maximum ﬂap opening 10.48 1.11–98.86 0.043
Maximum ﬂap length 5.42 1.86–15.82 0.008
Number of ﬂaps per dissection 2.20 1.05–4.62 0.039
Dissection length, mm 1.03 1.03–1.06 0.008
OCT ¼ optical coherence tomography.but that was not signiﬁcantly different from nondissected
edges (30.7%, p ¼ 0.137). Notwithstanding, the circum-
ferential extension, but not the simple presence of calciﬁ-
cation, was identiﬁed as an independent predictor of stent
edge dissection (OR: 1.02 for every 1 increase; 95% CI:
1.00 to 1.03, p ¼ 0.017). OCT enabled assessment of
calcium depth, but this was not associated with occurrenceDissection
No Dissection
(n ¼ 123)
Overall
(n ¼ 88)
Treated
(n ¼ 22)
Not Treated
(n ¼ 66)
MACE 7 (7.95%) 1 (4.54%) 6 (9.09%) 7 (5.69%)
All-cause death 3 (3.40%) 0 3 (4.54%) 5 (4.06%)
Cardiac death 1 (1.13%) 0 1 (1.51%) 4 (3.25%)
Nonfatal MI 4 (4.54%) 1 (4.54%) 3 (4.54%) 3 (2.43%)
TVR 1 (1.13%) 0 1 (1.51%) 1 (0.81%)
TLR 1 (1.13%) 0 1 (1.51%) 1 (0.81%)
Deﬁnite/probable
stent thrombosis
0 0 0 1 (0.81%)
Values are n (%). There were no signiﬁcant statistical differences between groups.
MACE ¼ major adverse cardiac event(s); MI ¼ myocardial infarction; TLR ¼ target lesion
revascularization; TVR ¼ target vessel revascularization.
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812of dissection. An exploratory receiver-operating character-
istic curve analysis revealed an angle of calciﬁcation 72 to
be the best cutoff to predict calcium-related edge dissections,
with a sensitivity of 71.1% and speciﬁcity of 71.2%. These
results suggest that loss of circumferential vessel compliance
might be more important in the pathogenesis of calcium-
related dissections rather than the presence or depth of
calciﬁcation.
Mechanical factors, such as vessel overstretching by an
oversized stent relative to the reference vascular dimensions,
have also been suggested as an important cause of dissection
at stent edges. In the present study, we found signiﬁcantly
greater stent/artery ratios in dissected edges than in non-
dissected edges. For every 1% increase in stent diameter/
lumen diameter or stent area/lumen area ratios, the odds of
having a dissection increased 22% and 12%, respectively. As
anticipated, vessel overstretching was more pronounced in
the distal compared with the proximal dissected edges. Of
note, the mean stent/lumen diameter and area ratios of 1.04
and 1.07 indicate an adequate stent sizing at proximal edges,
suggesting that other factors such as plaque type, FC
thickness, and circumferential calciﬁcation play a more
signiﬁcant role in proximal edge dissections.
OCT assessment of stent edge dissections and management.
Of all 106 dissections, 24 (22.6%) were treated with addi-
tional stents. As expected, treated dissections were longer,
more complex, and deeper in comparison to the dissections
left untreated. The presence of intramural hematoma did not
impact the decision to treat; only 3 of the 10 dissections with
intramural hematoma were treated. Operators were more
prone to treat dissections observed on both OCT and
angiography. Importantly, the time period of the study was
not identiﬁed as a predictor for the decision to treat, indi-
cating that the learning curve of interpreting OCT images
did not inﬂuence the decision to further intervene upon
dissected stent edges.
Clinical implications. The arterial wall usually responds to
mechanical injury through a series of cellular and molecular
mechanisms implicated in neointimal hyperplasia formation
and vessel remodeling, which ultimately may lead to reste-
nosis (36). In addition, plaque disruption with exposure of its
prothrombotic milieu may promote acute/subacute throm-
bosis (6,7). In fact, stent edge dissections have been associated
with increased short- and mid-term incidence of MACE and
stent thrombosis (4–7,37). In the present study, the 12-
month MACE rate was relatively low in patients with and
without edge dissections detected by OCT. Furthermore,
OCT morphometric characteristics of untreated dissections
in patients who developed MACE were not signiﬁcantly
different than dissections in patients who had uneventful
outcomes. Virtually all dissections presented with TIMI ﬂow
grade 3 at the end of the procedure and were classiﬁed as
National Heart, Lung, and Blood Institute type B or less.
These observations suggest that angiographically “silent”dissections seen only by OCT have minimal impact on
outcomes after stent deployment in modern PCI. However,
these ﬁndings should be interpreted with caution. The more
severe OCT-detected dissections were treated. As a result,
edge dissections left untreated were smaller in size, had
shorter longitudinal extension, and were usually more
superﬁcial, with their depths limited to the intimal/atheroma
layer (Table 6). Nevertheless, the present results are reas-
suring in that minor, non–ﬂow-limiting OCT-detected
dissections have a benign course and are not associated with
an increased incidence of adverse outcomes (34,38–41).
Study limitations. The present study is insufﬁcient to support
speciﬁc criteria to guide clinical decision making on which
OCT-detected dissection should be treated, but it indicates
that dissections with longitudinal length1.75 mm, with<2
concomitant ﬂaps, ﬂap depth0.52 mm, ﬂap opening0.33
mm, and not extending deeper than the media layer have
favorable outcomes and can be left untreated. Future studies
would be required to understand whether the more complex
characteristics of the treated dissections in the present study
would be associated with poor outcomes if left untreated.
However, such study will be difﬁcult to be conducted due to
the inherently ethical limitations of leaving potentially life-
threatening vascular complications untreated. Another
potential limitation is that the absence of serial OCT exam-
ination precludes conclusions on the mechanisms of stent
edge dissection healing and determination of predictors for
dissection persistence over time, aspects that need to be
investigated in future works.
Conclusions
Utilization of OCT in daily practice reveals a high rate of
stent-edge dissections. Dissections were associated with
atherosclerosis at the stent edge and PCI technique. A small
minority of dissections was angiographically evident, though
with detailed OCT assessment, subsequent management
was altered. Non–ﬂow-limiting, short, and superﬁcial
dissections proved to be benign when left untreated.Reprint requests and correspondence: Dr. Marco A. Costa,
Division of Cardiology, Harrington Heart & Vascular Institute,
University Hospitals Case Medical Center, Case Western Reserve
School of Medicine, 11,100 Euclid Avenue, Lakeside 3001,
Cleveland, Ohio 44106. E-mail: marco.costa@uhhospitals.org.
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